Physician profile
Lorena Tinoco
NPI 1952542839
$1,451.36
in general payments reported to CMS, 2019-2025
19 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $171 · 2021: $246 · 2022: $214 · 2023: $202 · 2024: $222 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $325.73 | 2020-2024 | Liletta, Lo Loestrin Fe |
| Coopersurgical, INC. | $164.18 | 2020-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $124.74 | 2022-2025 | Solosec, Phexx, Phexxi |
| Astellas Pharma US INC | $117.08 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $103.12 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Medicem INC. | $98.85 | 2021 | |
| Innovation Technologies INC | $95.33 | 2024-2025 | Irrisept |
| Shield Therapeutics INC | $69.59 | 2023-2025 | |
| Allergan, INC. | $61.72 | 2019 | |
| Mayne Pharma Commercial LLC | $57.00 | 2021-2023 | |
| Therapeuticsmd, INC. | $48.06 | 2020 | |
| Samsung Hme America, INC. | $30.00 | 2019 | |
| Mission Pharmacal Company | $28.32 | 2020-2021 | |
| Covidien Lp | $24.64 | 2019 | |
| Pfizer INC. | $23.96 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Regent | $23.15 | 2025 | Injectafer |
| Exeltis, USA INC. | $23.09 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $19.53 | 2019 | |
| Becton, Dickinson and Company | $13.27 | 2023 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorena Tinoco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.